K Layden
Non-Executive Director
Chemistry
Lincoln Pharma
Russian Federation
Biography
Deep understanding of chemical innovation and broad operational and management experience. Keith joined Croda in 1984 and was appointed to the Board as Chief Technology Office in February 2012. Until January 2016 he was responsible for the Technology Investment Group. Up until his retirement in April 2017 he was responsible for global R&D and was also President Life Sciences.
Research Interest
Chemistry
